Richard Lau, CFA - Profile and Investment Details

Investor Profile

Richard Lau, CFA is a Venture Capital, Private Equity Firm, Investor based in New York, United States with a diverse investment portfolio that includes companies such as AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology, Jounce Therapeutics, Wave Life Sciences, LifeMine TherapeuticsPeloton Therapeutics, 10X Genomics, Ardelyx, Adaptimmune, Cullinan Oncology, Kira Pharmaceuticals, Generation Bio, Relay Therapeutics, Protagonist Therapeutics, Decibel Therapeutics, Alector, Cue, Orchard Therapeutics, Crossover Health, Audentes Therapeutics, Tarsa Therapeutics, Verona Pharma, Aduro BioTech, Juvenescence, Genomics, Intarcia Therapeutics, Turning Point Therapeutics, Akari Therapeutics, Genapsys, Cerevance, SomaLogic, Bit Bio, Affinivax, Fulcrum Therapeutics, Inscripta, Intellia Therapeutics, Maze Therapeutics, Replimune Group, ALX Oncology, WaveTec Vision, Tempest Therapeutics, evonetix, HealthVerity, ORIC Pharmaceuticals, EverlyWell, Tasso, Vaxcyte, Delfi Diagnostics, Sequenta, REGENXBIO, Solid Biosciences, Keros Therapeutics, Nexvet, Venatorx Pharmaceuticals, Insitro, VelosBio, Mindstrong, Kinnate Biopharma, Kriya Therapeutics, Twist Bioscience, Aimmune Therapeutics, Element Biosciences, Pharvaris, Arcus Biosciences, DNAnexus, Nurix Therapeutics, Ivantis, SAGE Therapeutics, . Over time, Richard Lau, CFA has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Richard Lau, CFA is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Hospitals, Women Founded, Investment Management, Life Science, Artificial Intelligence (AI), Information Technology (IT), Analytics, Software, Biotechnology, Consumer Health, Electronic Health Records (EHR), Health and Hospital Services, Productivity Software, Health Diagnostics, Digital Health, Travel, Medical, Therapeutics, Media and Entertainment, Pharmaceuticals may find it worthwhile to explore potential connections with Richard Lau, CFA, as their portfolio suggests a familiarity and interest in this area.

Understanding Richard Lau, CFA’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.